Vorasidenib in IDH1/2-mutant low-grade glioma: the grey zone of patient's selection.

Front Oncol

Nervous System Medical Oncology Department, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.

Published: January 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809174PMC
http://dx.doi.org/10.3389/fonc.2023.1339266DOI Listing

Publication Analysis

Top Keywords

vorasidenib idh1/2-mutant
4
idh1/2-mutant low-grade
4
low-grade glioma
4
glioma grey
4
grey zone
4
zone patient's
4
patient's selection
4
vorasidenib
1
low-grade
1
glioma
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!